Maya Namboodiri, DO | |
855 Montgomery, Fort Worth, TX 76107-2553 | |
(817) 920-7000 | |
(817) 920-7147 |
Full Name | Maya Namboodiri |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 29 Years |
Location | 855 Montgomery, Fort Worth, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437128303 | NPI | - | NPPES |
87523G | Other | TX | BCBS |
P00297368 | Other | TX | RAILROAD MEDICARE |
038720101 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | K6177 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jps Health Network | Fort worth, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Acclaim Physician Group Inc | 4587963582 | 439 |
News Archive
An investigational material known Bioabsorbable Cardiac Matrix (BCM) that is injected through the coronary artery to prevent cardiac remodelling in heart attack patients had no significant effect compared to a saline placebo, according to results of the PRESERVATION I trial.
AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration with TESARO, Inc., an oncology-focused biopharmaceutical company.
A team of researchers at The University of Texas at San Antonio received a two-year, $387,000 grant, from the National Institutes of Health (NIH), to develop technology that will identify brain activity patterns that contribute to stuttering and use that technology to train people how to optimize brain functions.
Global leaders attending the US-hosted Global COVID-19 Summit on 22 September re-affirmed their commitment to ending the acute phase of the pandemic, and the goals of the ACT-Accelerator, by agreeing targets to provide equitable access to COVID-19 tests, treatments, and vaccines.
› Verified 4 days ago
Entity Name | Acclaim Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
An investigational material known Bioabsorbable Cardiac Matrix (BCM) that is injected through the coronary artery to prevent cardiac remodelling in heart attack patients had no significant effect compared to a saline placebo, according to results of the PRESERVATION I trial.
AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration with TESARO, Inc., an oncology-focused biopharmaceutical company.
A team of researchers at The University of Texas at San Antonio received a two-year, $387,000 grant, from the National Institutes of Health (NIH), to develop technology that will identify brain activity patterns that contribute to stuttering and use that technology to train people how to optimize brain functions.
Global leaders attending the US-hosted Global COVID-19 Summit on 22 September re-affirmed their commitment to ending the acute phase of the pandemic, and the goals of the ACT-Accelerator, by agreeing targets to provide equitable access to COVID-19 tests, treatments, and vaccines.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Maya Namboodiri, DO Po Box 99335, Fort Worth, TX 76199-0335 Ph: (817) 920-7000 | Maya Namboodiri, DO 855 Montgomery, Fort Worth, TX 76107-2553 Ph: (817) 920-7000 |
News Archive
An investigational material known Bioabsorbable Cardiac Matrix (BCM) that is injected through the coronary artery to prevent cardiac remodelling in heart attack patients had no significant effect compared to a saline placebo, according to results of the PRESERVATION I trial.
AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration with TESARO, Inc., an oncology-focused biopharmaceutical company.
A team of researchers at The University of Texas at San Antonio received a two-year, $387,000 grant, from the National Institutes of Health (NIH), to develop technology that will identify brain activity patterns that contribute to stuttering and use that technology to train people how to optimize brain functions.
Global leaders attending the US-hosted Global COVID-19 Summit on 22 September re-affirmed their commitment to ending the acute phase of the pandemic, and the goals of the ACT-Accelerator, by agreeing targets to provide equitable access to COVID-19 tests, treatments, and vaccines.
› Verified 4 days ago
Jonathan A Lazarini, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Fort Worth, TX 76104 Phone: 903-353-2265 | |
Mrs. Adeline Galvez, Family Medicine Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 270, Fort Worth, TX 76104 Phone: 817-250-4987 | |
Fomundam Newnton Mbuh, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 4759 South Fwy Ste 101, Fort Worth, TX 76115 Phone: 817-382-0005 | |
Dr. Joane Baumer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Family Medicine Center, Fort Worth, TX 76104 Phone: 817-335-1034 | |
Evelyn Tobias-merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 Stadium Dr, Fort Worth, TX 76109 Phone: 817-257-7940 | |
Dr. Michael David Carletti, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Montgomery St, Fort Worth, TX 76107 Phone: 817-735-0278 | |
Jonathan Patrick Angel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Beach St Ste 104, Fort Worth, TX 76111 Phone: 817-831-1750 Fax: 817-831-1750 |